Hot Flash Drug Elinzanetant Shows Strong Safety Record in Pooled Analysis of Four Clinical Trials
A pooled analysis of four randomized trials found the dual neurokinin receptor antagonist elinzanetant showed no liver toxicity or cancer ...
A pooled analysis of four randomized trials found the dual neurokinin receptor antagonist elinzanetant showed no liver toxicity or cancer ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.